article
2 June 2017 | By Carol V Robinson, Hsin-Yung Yen, Idlir Liko, Jonathan ST Hopper, Timothy Allison
Mass spectrometry (MS) performed under native-like conditions (nMS) is a promising approach for studying protein-drug interactions, and has already informed treatments of some of the most intractable diseases including cancer, diabetes and Alzheimer’s.